Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process - PubMed (original) (raw)
. 2002 Sep 13;277(37):34109-16.
doi: 10.1074/jbc.M204521200. Epub 2002 Jul 1.
Affiliations
- PMID: 12093810
- DOI: 10.1074/jbc.M204521200
Free article
Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process
Burkhard Fleckenstein et al. J Biol Chem. 2002.
Free article
Abstract
Tissue transglutaminase (TG2) can modify proteins by transamidation or deamidation of specific glutamine residues. TG2 has a major role in the pathogenesis of celiac disease as it is both the target of disease-specific autoantibodies and generates deamidated gliadin peptides that are recognized by CD4(+), DQ2-restricted T cells from the celiac lesions. Capillary electrophoresis with fluorescence-labeled gliadin peptides was used to separate and quantify deamidated and transamidated products. In a competition assay, the affinity of TG2 to a set of overlapping gamma-gliadin peptides was measured and compared with their recognition by celiac lesion T cells. Peptides differed considerably in their competition efficiency. Those peptides recognized by intestinal T cell lines showed marked competition indicating them as excellent substrates for TG2. The enzyme fine specificity of TG2 was characterized by synthetic peptide libraries and mass spectrometry. Residues in positions -1, +1, +2, and +3 relative to the targeted glutamine residue influenced the enzyme activity, and proline in position +2 had a particularly positive effect. The characterized sequence specificity of TG2 explained the variation between peptides as TG2 substrates indicating that the enzyme is involved in the selection of gluten T cell epitopes. The enzyme is mainly localized extracellularly in the small intestine where primary amines as substrates for the competing transamidation reaction are present. The deamidation could possibly take place in this compartment as an excess of primary amines did not completely inhibit deamidation of gluten peptides at pH 7.3. However, lowering of the pH decreased the reaction rate of the TG2-catalyzed transamidation, whereas the rate of the deamidation reaction was considerably increased. This suggests that the deamidation of gluten peptides by TG2 more likely takes place in slightly acidic environments.
Similar articles
- The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions.
Stamnaes J, Fleckenstein B, Sollid LM. Stamnaes J, et al. Biochim Biophys Acta. 2008 Nov;1784(11):1804-11. doi: 10.1016/j.bbapap.2008.08.011. Epub 2008 Aug 28. Biochim Biophys Acta. 2008. PMID: 18793760 Free PMC article. - A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S, Qiao SW, Sollid LM, Fleckenstein B. Dørum S, et al. J Proteome Res. 2009 Apr;8(4):1748-55. doi: 10.1021/pr800960n. J Proteome Res. 2009. PMID: 19239248 - Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.
Skovbjerg H, Koch C, Anthonsen D, Sjöström H. Skovbjerg H, et al. Biochim Biophys Acta. 2004 Nov 5;1690(3):220-30. doi: 10.1016/j.bbadis.2004.06.009. Biochim Biophys Acta. 2004. PMID: 15511629 - Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.
Rauhavirta T, Hietikko M, Salmi T, Lindfors K. Rauhavirta T, et al. Clin Rev Allergy Immunol. 2019 Aug;57(1):23-38. doi: 10.1007/s12016-016-8557-4. Clin Rev Allergy Immunol. 2019. PMID: 27263022 Review. - Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.
Martucciello S, Paolella G, Esposito C, Lepretti M, Caputo I. Martucciello S, et al. Cell Mol Life Sci. 2018 Nov;75(22):4107-4124. doi: 10.1007/s00018-018-2902-0. Epub 2018 Aug 22. Cell Mol Life Sci. 2018. PMID: 30136165 Free PMC article. Review.
Cited by
- Dermatitis herpetiformis: from the genetics to the development of skin lesions.
Bonciani D, Verdelli A, Bonciolini V, D'Errico A, Antiga E, Fabbri P, Caproni M. Bonciani D, et al. Clin Dev Immunol. 2012;2012:239691. doi: 10.1155/2012/239691. Epub 2012 Jun 7. Clin Dev Immunol. 2012. PMID: 22778763 Free PMC article. Review. - Localization of tissue transglutaminase and N (epsilon)-(gamma) -glutamyl lysine in duodenal cucosa during the development of mucosal atrophy in coeliac disease.
Sakly W, Sriha B, Ghedira I, Bienvenu F, Ayadi A, Sfar MT, Lachaux A, Korbi S, Bienvenu J, Fabien N. Sakly W, et al. Virchows Arch. 2005 Jun;446(6):613-8. doi: 10.1007/s00428-005-1237-z. Epub 2005 May 13. Virchows Arch. 2005. PMID: 15891906 - The immune recognition of gluten in coeliac disease.
Ciccocioppo R, Di Sabatino A, Corazza GR. Ciccocioppo R, et al. Clin Exp Immunol. 2005 Jun;140(3):408-16. doi: 10.1111/j.1365-2249.2005.02783.x. Clin Exp Immunol. 2005. PMID: 15932501 Free PMC article. Review. - Development of a Sequence Searchable Database of Celiac Disease-Associated Peptides and Proteins for Risk Assessment of Novel Food Proteins.
Amnuaycheewa P, Abdelmoteleb M, Wise J, Bohle B, Ferreira F, Tetteh AO, Taylor SL, Goodman RE. Amnuaycheewa P, et al. Front Allergy. 2022 May 26;3:900573. doi: 10.3389/falgy.2022.900573. eCollection 2022. Front Allergy. 2022. PMID: 35769554 Free PMC article. - Immunopathogenesis of celiac disease.
Tye-Din J, Anderson R. Tye-Din J, et al. Curr Gastroenterol Rep. 2008 Oct;10(5):458-65. doi: 10.1007/s11894-008-0085-9. Curr Gastroenterol Rep. 2008. PMID: 18799120
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials